Vaccine Response With NT-I7

Clinical trial NCT04054752 · WITHDRAWN

Trial details

NCT number: NCT04054752
Sponsor: National Cancer Institute (NCI)
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Carcinoma Colorectal Adenocarcinoma Bladder Carcinoma

Start date: 2023-05-30
Primary completion: 2023-11-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.